시장보고서
상품코드
1874589

세계의 세포 분리 기술 시장

Cell Separation Technologies

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 세포 분리 기술 시장은 2030년까지 598억 달러에 달할 전망

2024년에 257억 달러로 추정되는 세계의 세포 분리 기술 시장은 2024-2030년의 분석 기간에 CAGR 15.1%로 성장하며, 2030년까지 598억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 연구소·연구기관용은 14.9%의 CAGR을 기록하며, 분석 기간 종료까지 249억 달러에 달할 것으로 예측됩니다. 또 바이오테크놀러지·제약 산업용 부문의 성장률은 분석 기간에 16.4%의 CAGR로 추정되고 있습니다.

미국 시장은 71억 달러로 추정되는 한편, 중국은 14.1%의 CAGR로 성장할 것으로 예측됩니다.

미국의 세포 분리 기술 시장은 2024년에 71억 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 14.1%로 추이하며, 2030년까지 90억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 13.2%, 12.6%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 11.0%의 CAGR로 성장할 것으로 예측됩니다.

세계의 세포 분리 기술 시장 - 주요 시장 동향과 촉진요인의 개요

세포 분리 기술은 어떻게 생물 의학 연구를 촉진하고 있는가?

세포 분리 기술은 생물의학 연구의 기반이 되고 있습니다. 과학자들이 이질적인 혼합물에서 특정 세포 유형을 분리할 수 있는 능력을 제공하여 질병 메커니즘 연구, 치료법 개발, 기초 생물학 연구 수행에 필수적입니다. 이러한 기술은 면역학, 암 연구, 줄기세포 생물학 등의 용도에서 세포의 거동과 기능을 이해하기 위해 특정 세포 집단을 분리하는 것이 매우 중요하므로 필수적인 역할을 하고 있습니다. 예를 들어 면역세포를 정밀하게 분리함으로써 연구자들은 감염이나 치료법에 대한 면역반응을 조사할 수 있고, 이는 새로운 면역치료법 개발로 이어질 수 있습니다. 암 연구에서는 종양세포를 정상세포와 분리하여 암의 진행과 치료에 대한 반응을 자세히 분석할 수 있습니다. 자기 활성화 세포 선별(MACS), 형광 활성화 세포 선별(FACS), 마이크로플루이딕스 기반 시스템 등 다양한 기술이 이러한 목적을 달성하기 위해 널리 사용되고 있으며, 세포의 유형과 필요한 정확도에 따라 각각 고유한 이점을 제공합니다. 연구 및 임상 현장에서 이러한 기술의 보급은 학술기관과 산업 연구소 모두에서 그 중요성이 확대되고 있습니다.

세포 분리 기술이 치료제 개발에 중요한 이유는 무엇인가?

세포 분리 기술은 특히 세포 기반 치료법 및 맞춤형 의료를 창출하는 데 있으며, 치료제 개발에 매우 중요한 역할을 합니다. 재생의료, 면역치료 등의 분야에서는 치료 목적으로 사용할 수 있는 고순도 세포 집단을 생성하기 위해 특정 세포 유형을 분리하는 것이 필수적입니다. 예를 들어 CAR-T 세포치료는 면역세포를 분리, 유전자 변형, 증식시킨 후 환자에게 재투여하여 암세포를 표적화하여 파괴하는 치료법입니다. 분리된 세포의 순도와 생존율은 치료 성공의 핵심입니다. 마찬가지로 줄기세포 치료는 골수나 조직에서 줄기세포를 분리하는 기술이 사용되어 손상된 조직의 재생이나 퇴행성 질환 치료에 응용되고 있습니다. 치료법 개발 외에도 이러한 기술은 임상 진단 분야에서도 활용되고 있습니다. 혈액이나 조직 샘플에서 특정 세포를 분리하여 보다 정확한 질병을 검출하고 경과를 관찰할 수 있습니다. 높은 처리량과 고정밀도의 세포 분리 능력은 개인 맞춤형 치료법 개발 및 정밀의료의 발전에 새로운 가능성을 제시하고 있습니다. 정밀의료에서는 환자 개개인의 고유한 세포 프로파일에 따라 치료법이 조정됩니다.

기술 혁신은 세포 분리 기술을 어떻게 향상시키고 있는가?

기술 발전으로 세포 분리 기술의 효율성, 정확성, 확장성이 크게 향상되어 연구개발 및 임상 응용 모두에서 보다 접근하기 쉽고 신뢰할 수 있게 되었습니다. 주요 혁신 중 하나는 자동화된 고처리량 세포 선별 시스템의 개발입니다. 이를 통해 최소한의 인위적 개입으로 대량의 샘플을 신속하게 처리할 수 있게 되었습니다. 이러한 시스템은 속도와 정확성이 매우 중요한 신약 개발 및 임상 현장에서 특히 가치가 있습니다. 마이크로플루이딕스 기술은 세포를 미세한 규모로 조작할 수 있게 하여 보다 정밀하고 부드러운 선별 방법을 실현함으로써 세포 분리에 혁명을 일으켰습니다. 이를 통해 세포 손상을 줄이고 분리된 세포의 생존율을 향상시켰습니다. 또한 음향 분리 및 유전체 영동 기반 분리와 같은 라벨이 필요 없는 기술의 발전은 세포의 무결성을 유지하면서 기존의 라벨링 방법을 대체할 수 있는 대안을 제공함으로써 이러한 기술을 섬세한 용도에 적합하게 만들고 있습니다. 또한 인공지능(AI)과 머신러닝을 세포 선별 워크플로우에 통합하여 선별 매개변수 분석 및 최적화 능력을 향상시켜 세포 분리의 효율성과 정확성을 더욱 높이고 있습니다. 이러한 혁신은 차세대 세포 분리 기술을 촉진하고, 단일 세포 분석, 암 연구, 재생 의학 등의 분야에서 응용을 확대하고 있습니다.

세포 분리 기술 시장의 주요 성장 요인은 무엇인가?

세포 분리 기술 시장의 성장은 세포 기반 연구의 발전, 맞춤형 의료의 부상, 치료 개발에서 고순도 세포 집단에 대한 수요 증가 등 여러 요인에 의해 촉진되고 있습니다. 주요 촉진요인 중 하나는 CAR-T 세포 치료, 줄기세포 치료 등 세포 기반 치료법 개발에 있으며, 효율적인 세포 분리의 필요성이 증가하고 있다는 점입니다. 이러한 치료법은 효능과 안전성을 보장하기 위해 특정 세포 유형을 정확하게 분리해야 하며, 이는 첨단 분리 기술에 대한 수요를 촉진하고 있습니다. 자동화 및 고처리량 선별 시스템과 같은 기술 혁신은 연구자들이 대량의 샘플을 신속하고 정확하게 처리할 수 있게 하여 시장 성장에 더욱 기여하고 있습니다. 또한 유전체학 및 단백질체학 분야에서 단일 세포 분석의 확대는 상세한 분자 연구를 위해 고도로 정제된 세포 집단을 필요로 하는 연구자들에게 세포 분리 기술에 새로운 기회를 창출하고 있습니다. 치료제 개발에 있으며, 분리세포에 크게 의존하는 면역치료와 재생의료의 부상도 수요를 견인하고 있습니다. 또한 정부와 민간의 생명과학 연구에 대한 투자 증가와 암, 자가면역질환 등 만성질환의 유병률 증가로 인해 첨단 세포분리 기술의 필요성이 가속화되고 있습니다. 이러한 요인에 더해 임상 진단 및 신약 개발 분야에서 세포 분리 기술의 활용이 확대됨에 따라 향후 수년간 세포 분리 기술 시장의 견고한 성장이 지속될 것으로 예측됩니다.

부문 :

최종사용자별(연구소, 바이오테크놀러지·제약 업계, 기타 최종사용자)

조사 대상 기업의 예

  • BD Biosciences
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • pluriSelect Life Science
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석 방식을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM(거대 언어 모델)이나 산업 특화 SLM(소규모 언어 모델)에 대한 쿼리 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA

Global Cell Separation Technologies Market to Reach US$59.8 Billion by 2030

The global market for Cell Separation Technologies estimated at US$25.7 Billion in the year 2024, is expected to reach US$59.8 Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Research Laboratories & Institutes End-Use, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$24.9 Billion by the end of the analysis period. Growth in the Biotechnology & Pharmaceutical Industries End-Use segment is estimated at 16.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 14.1% CAGR

The Cell Separation Technologies market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.0 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.2% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Cell Separation Technologies Market - Key Trends and Drivers Summarized

How Are Cell Separation Technologies Advancing Biomedical Research?

Cell separation technologies have become fundamental to biomedical research, providing scientists with the ability to isolate specific cell types from heterogeneous mixtures, which is critical for studying disease mechanisms, developing therapies, and conducting basic biological research. These technologies are essential for applications such as immunology, cancer research, and stem cell biology, where isolating specific cell populations is crucial to understanding cellular behavior and function. By enabling the precise separation of immune cells, for instance, researchers can investigate immune responses to infections or therapies, leading to the development of new immunotherapies. In cancer research, separating tumor cells from healthy cells allows for detailed analysis of how cancer progresses and responds to treatments. Various techniques, such as magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic-based systems, are commonly used to achieve these goals, each offering unique advantages depending on the cell type and the level of precision required. The widespread use of these technologies across research and clinical settings has expanded their relevance in both academic and industrial laboratories.

Why Are Cell Separation Technologies Critical for Therapeutic Development?

Cell separation technologies play a pivotal role in therapeutic development, particularly in the creation of cell-based therapies and personalized medicine. In fields such as regenerative medicine and immunotherapy, isolating specific cell types is essential for generating high-purity cell populations that can be used for therapeutic purposes. For example, in CAR-T cell therapy, immune cells are isolated, genetically engineered, expanded, and reintroduced to a patient to target and destroy cancer cells. The purity and viability of the isolated cells are critical for the success of these therapies. Similarly, in stem cell therapies, cell separation technologies are used to isolate stem cells from bone marrow or other tissues, allowing for their use in regenerating damaged tissues or treating degenerative diseases. In addition to therapeutic development, these technologies are used in clinical diagnostics, where separating specific cells from blood or tissue samples enables more accurate disease detection and monitoring. The ability to achieve high-throughput and high-precision cell isolation has opened new possibilities in developing targeted treatments and advancing precision medicine, where therapies are tailored to individual patients based on their unique cellular profiles.

How Are Technological Innovations Enhancing Cell Separation Techniques?

Technological advancements have significantly enhanced the efficiency, accuracy, and scalability of cell separation technologies, making them more accessible and reliable for both research and clinical applications. One of the key innovations is the development of automated, high-throughput cell sorting systems, which enable the rapid processing of large sample volumes with minimal human intervention. These systems are particularly valuable in drug discovery and clinical settings, where speed and precision are critical. Microfluidic technologies, which allow for the manipulation of cells at the microscale, have revolutionized cell separation by enabling more precise and gentle sorting methods, reducing cell damage and improving the viability of isolated cells. Additionally, advancements in label-free techniques, such as acoustic and dielectrophoresis-based separation, provide alternatives to traditional labeling methods, preserving cell integrity and making these technologies suitable for sensitive applications. Moreover, the integration of artificial intelligence (AI) and machine learning into cell sorting workflows has improved the ability to analyze and optimize sorting parameters, further increasing the efficiency and accuracy of cell separation. These innovations are driving the next generation of cell separation technologies, expanding their applications in areas like single-cell analysis, cancer research, and regenerative medicine.

What Are the Key Growth Drivers in the Cell Separation Technologies Market?

The growth in the cell separation technologies market is driven by several factors, including advancements in cell-based research, the rise of personalized medicine, and the increasing demand for high-purity cell populations in therapeutic development. One of the primary drivers is the growing need for efficient cell separation in the development of cell-based therapies, such as CAR-T cell therapy and stem cell treatments. These therapies require the precise isolation of specific cell types to ensure their effectiveness and safety, fueling demand for advanced separation technologies. Technological innovations, such as automated and high-throughput sorting systems, are making it easier for researchers to process large numbers of samples quickly and accurately, further contributing to market growth. Additionally, the expansion of single-cell analysis in genomics and proteomics is creating new opportunities for cell separation technologies, as researchers require highly purified cell populations for detailed molecular studies. The rise of immunotherapy and regenerative medicine, both of which rely heavily on isolated cells for treatment development, is also driving demand. Furthermore, increasing government and private investment in life sciences research, coupled with the growing prevalence of chronic diseases like cancer and autoimmune disorders, is accelerating the need for advanced cell separation techniques. These factors, along with the expanding use of cell separation in clinical diagnostics and drug discovery, are expected to sustain the robust growth of the cell separation technologies market in the years to come.

SCOPE OF STUDY:

The report analyzes the Cell Separation Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • BD Biosciences
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • pluriSelect Life Science
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Cell Separation Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Expands Use of Cell Separation in Diagnostics and Research
    • Rising Demand for Immunotherapy Expands Market for Cell Separation Technologies
    • Advancements in Microfluidics Propel Growth in Precision Cell Separation
    • Increasing Focus on Single-Cell Analysis Drives Adoption of Advanced Separation Technologies
    • Growing Application of Cell Separation in Cancer Research Strengthens Market Growth
    • Expansion of Stem Cell Therapy Boosts Demand for Efficient Cell Separation Solutions
    • Increased Need for High-Purity Cells in Biopharmaceutical Production Fuels Market Expansion
    • Rising Use of Cell Separation Technologies in Personalized Medicine Propels Market Growth
    • Adoption of Magnetic and Fluorescence-Activated Cell Sorting (MACS and FACS) Strengthens Cell Separation Market
    • Advances in Acoustic and Dielectrophoresis-Based Separation Drive Innovation in the Market
    • Increased Focus on Regenerative Medicine Fuels Demand for Sophisticated Cell Separation Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Separation Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Separation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Separation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Separation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biotechnology & Pharmaceutical Industries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biotechnology & Pharmaceutical Industries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cell Separation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Cell Separation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Rest of Europe 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Separation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Asia-Pacific 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Cell Separation Technologies by End-Use - Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of World 15-Year Perspective for Cell Separation Technologies by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Biotechnology & Pharmaceutical Industries and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제